146 related articles for article (PubMed ID: 27168163)
21. Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells.
Yu H; Li Q; Zhou X; Kolosov VP; Perelman JM
J Biochem Mol Toxicol; 2012 May; 26(5):179-86. PubMed ID: 22566028
[TBL] [Abstract][Full Text] [Related]
22. Activation of TRPV1 channel by dietary capsaicin improves visceral fat remodeling through connexin43-mediated Ca2+ influx.
Chen J; Li L; Li Y; Liang X; Sun Q; Yu H; Zhong J; Ni Y; Chen J; Zhao Z; Gao P; Wang B; Liu D; Zhu Z; Yan Z
Cardiovasc Diabetol; 2015 Feb; 14():22. PubMed ID: 25849380
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the sensory effects of tacrolimus on the skin.
Pereira U; Boulais N; Lebonvallet N; Pennec JP; Dorange G; Misery L
Br J Dermatol; 2010 Jul; 163(1):70-7. PubMed ID: 20302583
[TBL] [Abstract][Full Text] [Related]
24. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
[TBL] [Abstract][Full Text] [Related]
25. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
[TBL] [Abstract][Full Text] [Related]
26. Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes.
Li WH; Lee YM; Kim JY; Kang S; Kim S; Kim KH; Park CH; Chung JH
J Invest Dermatol; 2007 Oct; 127(10):2328-35. PubMed ID: 17508023
[TBL] [Abstract][Full Text] [Related]
27. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.
Gavva NR; Bannon AW; Hovland DN; Lehto SG; Klionsky L; Surapaneni S; Immke DC; Henley C; Arik L; Bak A; Davis J; Ernst N; Hever G; Kuang R; Shi L; Tamir R; Wang J; Wang W; Zajic G; Zhu D; Norman MH; Louis JC; Magal E; Treanor JJ
J Pharmacol Exp Ther; 2007 Oct; 323(1):128-37. PubMed ID: 17652633
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of TRPV1 for the treatment of sensitive skin.
Kueper T; Krohn M; Haustedt LO; Hatt H; Schmaus G; Vielhaber G
Exp Dermatol; 2010 Nov; 19(11):980-6. PubMed ID: 20626462
[TBL] [Abstract][Full Text] [Related]
29. A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration.
Waning J; Vriens J; Owsianik G; Stüwe L; Mally S; Fabian A; Frippiat C; Nilius B; Schwab A
Cell Calcium; 2007 Jul; 42(1):17-25. PubMed ID: 17184838
[TBL] [Abstract][Full Text] [Related]
30. Surfactant cocamide monoethanolamide causes eye irritation by activating nociceptor TRPV1 channels.
Zhao F; Wang S; Li Y; Wang J; Wang Y; Zhang C; Li Y; Huang L; Yu Y; Zheng J; Yu B; Pessah IN; Cao Z
Br J Pharmacol; 2021 Sep; 178(17):3448-3462. PubMed ID: 33837959
[TBL] [Abstract][Full Text] [Related]
31. A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation.
Klionsky L; Tamir R; Holzinger B; Bi X; Talvenheimo J; Kim H; Martin F; Louis JC; Treanor JJ; Gavva NR
J Pharmacol Exp Ther; 2006 Oct; 319(1):192-8. PubMed ID: 16844842
[TBL] [Abstract][Full Text] [Related]
32. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
[TBL] [Abstract][Full Text] [Related]
33. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
[TBL] [Abstract][Full Text] [Related]
34. Thermo-sensitive transient receptor potential vanilloid channel-1 regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells.
Mergler S; Skrzypski M; Sassek M; Pietrzak P; Pucci C; Wiedenmann B; Strowski MZ
Cell Signal; 2012 Jan; 24(1):233-46. PubMed ID: 21945155
[TBL] [Abstract][Full Text] [Related]
35. Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system.
Bianchi BR; Lee CH; Jarvis MF; El Kouhen R; Moreland RB; Faltynek CR; Puttfarcken PS
Eur J Pharmacol; 2006 May; 537(1-3):20-30. PubMed ID: 16630609
[TBL] [Abstract][Full Text] [Related]
36. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers.
Gibson RA; Robertson J; Mistry H; McCallum S; Fernando D; Wyres M; Yosipovitch G
PLoS One; 2014; 9(7):e100610. PubMed ID: 25047038
[TBL] [Abstract][Full Text] [Related]
37. Pain-enhancing mechanism through interaction between TRPV1 and anoctamin 1 in sensory neurons.
Takayama Y; Uta D; Furue H; Tominaga M
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5213-8. PubMed ID: 25848051
[TBL] [Abstract][Full Text] [Related]
38. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1.
Marincsák R; Tóth BI; Czifra G; Szabó T; Kovács L; Bíró T
Anesth Analg; 2008 Jun; 106(6):1890-6. PubMed ID: 18499628
[TBL] [Abstract][Full Text] [Related]
39. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
Shimizu I; Iida T; Horiuchi N; Caterina MJ
J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
[TBL] [Abstract][Full Text] [Related]
40. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
